Page 4 - Analytical Development News Today

Toronto, ON (PRWEB) September 29, 2022 -- Biological macromolecules (monoclonal antibodies, recombinant proteins, fusion proteins, antibody-drug-conjugates,

/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company harnessing the power of myeloid and innate biology to...

/PRNewswire/ -- Final days to register for the "Analytical Instrument Qualification and System Validation" training course that has been added to...

Here, Sridhar Pennathur of Novavax highlights the value of next generation sequencing in their vaccine production operations.

ICH's new draft guidance (Q14) for Analytical Procedure Development describes an enhanced approach for method development, validation, and life...

/PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory...

/PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory...

BERKELEY, Calif., May 12, 2022 /PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic pl...

Anindya Ghosh, Managing Director, Ferring Laboratories Private Limited said, " this site in Hyderabad is an integrated facility with R&D and manufacturing capability. The manufacturing facility is...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced FUJIFILM Diosynth Biotechnologies, a su...